Top Tweets for #LiverConnect
Amazing time at #LiverConnect! Great to review the latest updates and connect with colleagues and partners. Among the best liver conferences. @pgholam @AshinaSingh2 @tweetcldf
Kicking off the 6th Annual #LiverConnect Conference in sunny 🌞 Chula Vista, CA! Thrilled to connect with experts, dive into updates across viral hepatitis, MASH/MASLD, cholestatic & alcohol-related liver disease, and soak up cutting-edge clinical insights. Proud to present three posters and learn from colleagues from around the country. Let’s make this a great few days!
#Hepatology #LiverDisease #MASLD #MASH #ViralHepatitis #MedTwitter #GI #MedicalConference #GiTwitter #CLDF #LiverConnect
“A room with a view” is often overstated but certainly not in this case.
A gorgeous day on the banks of the #bosphorusstrait
Looking forward to a day of great scientific exchange with colleagues at @AASLDtweets @tkadorg #liverconnect meeting in #Istanbul
#livertwitter
@WRayKimMD with a provocative talk on the theme of screening for #MASLD #MASH : who why?
on the opening day of the @AASLDtweets @tkadorg #liverconnect meeting in #Istanbul
Lots of data gaps and grey zones. Definitely worth an encore stateside!
#livertwitter
📸 Excited to see our MDs representing us at the @CLDFoundation Liver Connect conference! 🌟 Their dedication to advancing liver health is truly inspiring. #LiverConnect2025 #LiverTwitter #LiverConnect25 #LiverConnect #GITwitter
A great way to start the #Persian New Year 🌸🪻🌼 Excellent autoimmune and cholestatic liver disease session with an inspiring Keynote talk by Dr. Patrick Kamath on loving what you do and finding joy in your career @CLDFoundation #liverconnect @rajVuppaLanchi @clbowlus @craiglammertIU @AparnaGoelMD 🪻🪻Happy Spring #Nowruz
Excited to share that i have 4 abstracts accepted to Liver connect 5th annual conference 🥳.. I will be presenting March 20th. Please join us !
#Liverconnect
#CLDFFoundation
The Liver Connect Conference is right around the corner! Join us in San Antonio, TX this March 20-22 and take advantage of forward-thinking keynote speakers, networking with influential key opinion leaders, industry, and much more. Register now at https://t.co/um8uamiOHr.
On #WorldHealthDay2024, with #LiverConnect just behind us, we ask @WHO to address MASLD and MASH as a public health priority on par with other NCDs:
MASLD/MASH research priorities:
https://t.co/B0gi5IekZo
Action priorities:
https://t.co/yGpI0H0IMb
#LiverTwitter #SLDthinktank
Happy #WorldHealthDay!
Today, we champion the right of everyone, everywhere to have access to:
-quality health services
-education
-health information
-safe drinking water
-clean air
-good nutrition
-quality housing
-decent working
-environmental conditions
-freedom from discrimination
#MyHealthMyRight
Just concluded my first #LiverConnect conference in Scottdale, AZ 🌵 . Grateful for the insightful sessions that fuel my passion to push boundaries in #hepatology and #endohepatology. Special thanks to @CLDFoundation, @UMN_GIHep, and @LizzieAbyMD for their invaluable support.
In what may be a case of saving the best for last (out of a fantastic @CLDFoundation #liverconnect meeting), @NoureddinMD with a tour de force covering #MASH from NITs to how to select appropriate #rezdiffra patients to measured optimism about the future #livertwitter
@DrLoomba @AlinaAllenMD @LiverConnect @CLDFoundation @schattenbergJ @brennap9 @Aurorabbelles @scottisaacsmd @ajay_duseja @mromerogomez @NoureddinMD @AlkhouriNaim @ebtapper @FattyLiverA @AEEHLiver @DrJavierCrespo @jturnesv @DrJLCalleja @AleksanderKrag @MajaThiele @SagiZelber @JonathanStineMD @MayoClinicGIHep @LiverInt @CommsMedicine @HEP_Journal @lucavalenti75 @mcolombo46 @AinaNico @DelfinaBoudou @aelsharkawy75 @marurinella @JCabezasGlez @Dr_Ampuero @Camilla_Dalby @FrancqueSven Thank you @CLDFoundation for another great #LiverConnect. Next up is the #SLDthinktank in Barcelona on 3-4 May https://t.co/5kdOcYEChL
We can still squeeze in a few more participants, so join us in setting the future agenda of MASLD and MASH
#LiverTwitter
Dr. @SagiZelber shared a fantastic presentation today at #liverconnect and very clearly outlined the most effective options for a healthy lifestyle for patients with MASLD and MASH, and really for anyone who wants a healthier lifestyle!
Dr. Zelber-Sagi shared her lifestyle and dietary recommendations for managing MASLD and hopefully preventing MASH and advanced liver disease. She emphasized that diet plans can be personalized to fit the patient's unique experiences and preferences, implying that while the Mediterranean diet is the recommended basis, it can be adapted according to individual needs and circumstances.
Take Home Messages:
1. The evidence for the benefit of restrictive diets like ketogenic, very-low-calorie diets, and intermittent fasting in MASLD Is scarce
2. A diet based on healthy eating patterns of minimally or unprocessed foods, low in sugar and saturated fat, high in polyphenols, and healthy fats (mono-and omega-3 polyunsaturated fats) is evidenced-based for the treatment of MASLD
3. The Mediterranean diet and similar patterns should serve as a basis that can be restructured into other kinds of diets
4. The type of diet can be tailored to the patient's experience and preferences
#livertwitter #liverconnect #liverx @ZobairYounossi @JVLazarus @VCU_Liver @GlobalLiver @EuropeLiver @Mayo_liverdoc @surfing_MASH @LiverScanDirect @MadrigalPharma @ISGLOBALorg @scottisaacsmd @EASLnews @AASLDtweets @CanNASHNetwork @AlinaAllenMD @AlkhouriNaim
Fabulous overview by @NoureddinMD, in his presentation today at #LiverConnect. The topic was “Major Advancements in MASH Management”.
Here are some take-aways from this very comprehensive presentation. We did utilize AI tools to assist and checked for accuracy.
1. Importance of Non-Invasive Tests (NITs) for MASH Diagnosis and Management. Dr. Noureddin emphasized the crucial role of non-invasive tests (NITs) for screening, diagnosing, and managing MASH (Metabolic Associated Steatohepatitis). He discussed the utility of various NITs in assessing disease severity and response to therapy, underlining the move away from invasive liver biopsies towards more patient-friendly approaches in clinical practice.
2. Advancements in MASH Treatment and FDA-approved Therapies: Dr. Noureddin highlights significant progress in the treatment of MASH, including the introduction of an FDA-approved therapy, resmetirom. He discusses the criteria for initiating treatment resmetirom, based on NIT results, and outlines guidelines for monitoring therapy effectiveness and making adjustments as necessary.
3. Combination of Serum and Imaging NITs Offers Best Diagnostic Accuracy: Dr. Noureddin notes that while both serum and imaging NITs have made significant strides, combining these methods provides the most accurate diagnostic and prognostic information. This approach helps in better predicting treatment responses and avoiding more costly or invasive tests.
4. Future of MASH Drug Development and Clinical Trials: Dr. Noureddin provides insights into ongoing and future directions in MASH drug development. He covered various drugs in the pipeline, including GLP-1 agonists and FGF21 analogs, highlighting the importance of continuous research and clinical trials to improve treatment options for patients with MASH.
5. Role of Healthcare Professionals in MASH Management: Dr. Noureddin called for a collective effort among healthcare professionals to advance drug development for MASH, ensuring that patients have access to effective treatments.
He stressed the need for hepatologists, gastroenterologists, and primary care physicians to stay informed about the latest advancements and to participate actively in research and clinical trials.
Overall, the presentation underscored the evolving landscape of MASH management, the critical role of NITs in diagnosis and treatment, and the promising future of drug development for MASH.
#livertwitter #liverx @ZobairYounossi @VCU_Liver
@Mayo_liverdoc @surfing_MASH @LiverScanDirect @MadrigalPharma
Conference Summary & Closing Remarks with Dr. Kim Brown! @livermama1 #LiverConnect #LiverTwitter
@livermama1 with concluding remarks. @CLDFoundation #liverconnect meeting is growing and will be happening around the same time next year. #livertwitter
The fourth MASH presentation at #LiverConnect was by @SagiZelber (Prof. Shira Zelber-Sagi) where she presented incredibly helpful data about "Lifestyle Recommendations in Clinical Practice.”
"Patients should choose the best 'diet' for them".
Ultra-Processed Food (UPF) (More than 5 ingredients"):
Industrial processes
Packaging with plastic and other synthetic materials
Highly profitable (low-cost ingredients, long shelf life)
Hyper-palatable
Low nutritional quality, contains many ingredients (≥5), and preservatives
Animal foods: animal fat, dairy products, eggs, fish-seafood, meat
Unhealthy plant foods: refined grains, potatoes, sweets-deserts, sugared beverages
Best choices: Healthy plant foods: whole grains, fruits, vegetables, nuts, legumes
"Every 2,500 steps reduces MASLD incidence 47%"
Exercise in the Management of MASLD in Adults
- A Position Statement From Exercise and Sport Science Australia
- Aerobic exercise and/or HIIT should be prioritized for the management of hepatic steatosis.
- The benefits of resistance training in isolation are unclear
- Resistance training should be included in addition to the recommended volume of aerobic exercise but not instead of it
- Unclear whether exercise can independently improve liver histology
#livertwitter #liverconnect
@ZobairYounossi @JVLazarus @VCU_Liver @GlobalLiver @EuropeLiver @Mayo_liverdoc @surfing_MASH @LiverScanDirect
The fifth enlightening presentation, and focused on MASH at the #LiverConnect conference was by @Mayo_liverdoc (Dr. Manal Abdelmalek) on Drug Treatment for MASH in 2024.
Goals of Any Treatment for MASH:
- Improve metabolic abnormalities
- Decrease inflammation
- Prevent / arrest / reverse liver fibrosis
- Prevent liver failure, liver cancer and liver-related outcomes
- Improve systemic outcomes (eventually) including risk for new incident diabetes mellitus, CVD, and CKD
- Acceptable safety profile
"Strong Label Positions Resmetirom Well in Emerging Landscape as Foundational Therapy: NOW APPROVED Rezdiffra: resmetirom tablets
60mg • 00mg - 100mg
Indicated for the treatment of NASH with moderate to advanced liver fibrosis (F2/F3)
* No biopsy requirement in label
* Once-daily, oral; simple dosing
* No contraindications; no boxed warning;
* no monitoring requirements beyond SOC
Landmark label for first FDA-approved medicine for NASH sets standard for potential future treatments"
Also discussed were Semaglutide, Lanifibranor and FGF21s for MASH, both in clinical trials.
#livertwitter #liverconnect #liverx
@ZobairYounossi @JVLazarus @VCU_Liver @GlobalLiver @EuropeLiver @Mayo_liverdoc @surfing_MASH @LiverScanDirect @MadrigalPharma
Fantastic @CLDFoundation #liverconnect session on autoimmune liver disease @lilydaramd @autoimmuneliver @rajVuppaLanchi @clbowlus @AparnaGoelMD @craiglammertIU #livertwitter
Thank you for joining us at tonights reception! 🥂#LiverConnect
Now join Dr. Abdelmalek @Mayo_liverdoc for her talk "Drug Treatment for MASH in 2024"! #LiverConnect #LiverTwitter
Last Seen Hashtags on Sotwe
background
Seen from United States
ODSP
Seen from United States
ลำลูกกา
Seen from Thailand
elizabethmarquez
Seen from Mexico
Öpüşme
Seen from Turkey
zoomjakolph
Seen from Philippines
humantoilet
Seen from Germany
สาวใหญ่โคราช
Seen from Thailand
pakistani leak video
Seen from Pakistan
Dildo
Seen from Kenya
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.2M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
87M followers
Taylor Swift
@taylorswift13
80.8M followers
Lady Gaga
@ladygaga
72.3M followers
Kim Kardashian
@kimkardashian
69.5M followers
Virat Kohli
@imvkohli
68.8M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.5M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.4M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.1M followers